Abstract
Conclusion
Nine patients who received aureomycin, 9 patients who received chloramphenicol, 7 patients who received streptomycin and 6 patients who received terramycin failed to show any influence of p-(di-n-propylsulfamyl)-benzoic acid, ‘Benemid’, administered orally every 6 hours in a dose of 0.5 g on the plasma concentrations of the respective antibiotic agents. The failure of ‘Benemid’ to increase the plasma concentrations of streptomycin indicates that ‘Benemid’ may be administered safely to patients who are receiving streptomycin in conjunction with PAS.
Get full access to this article
View all access options for this article.